Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In other words, the price has increased by $0.00 from its previous closing price. On the day, 5.43 million shares were traded. HIMS stock price reached its highest trading level at $14.94 during the session, while it also had its lowest trading level at $14.37.
Ratios:
For a deeper understanding of Hims & Hers Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 35.73. For the most recent quarter (mrq), Quick Ratio is recorded 2.30 and its Current Ratio is at 2.68. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
Citigroup Downgraded its Buy to Neutral on May 22, 2024, whereas the target price for the stock was revised from $16 to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 27 ’24 when Pendarvis Christiane sold 7,000 shares for $15.15 per share. The transaction valued at 106,064 led to the insider holds 23,917 shares of the business.
Pendarvis Christiane bought 7,000 shares of HIMS for $106,067 on Aug 27 ’24. On Aug 20 ’24, another insider, Boughton Soleil, who serves as the Chief Legal Officer of the company, sold 2,334 shares for $16.71 each. As a result, the insider received 39,001 and left with 162,141 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 3197588224 and an Enterprise Value of 2981769472. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 196.93, and their Forward P/E ratio for the next fiscal year is 25.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.00 while its Price-to-Book (P/B) ratio in mrq is 8.82. Its current Enterprise Value per Revenue stands at 2.794 whereas that against EBITDA is 111.306.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $25.74, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is -23.49%, while the 200-Day Moving Average is calculated to be 4.30%.
Shares Statistics:
For the past three months, HIMS has traded an average of 10.06M shares per day and 7392700 over the past ten days. A total of 205.10M shares are outstanding, with a floating share count of 164.10M. Insiders hold about 24.41% of the company’s shares, while institutions hold 57.40% stake in the company. Shares short for HIMS as of 1723680000 were 23042592 with a Short Ratio of 2.29, compared to 1721001600 on 19812630. Therefore, it implies a Short% of Shares Outstanding of 23042592 and a Short% of Float of 12.100001.
